VRNA vs. SMMT

Last updated Jun 9, 2026

VRNA (Verona Pharma plc) and SMMT (Summit Therapeutics Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.10 correlation, their price movements are largely independent.

Performance

VRNA vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

SMMT

• 1D: -4.47%
• 1M: -21.96%
• YTD: -19.33%
• 6M: -24.24%
• 1Y: -31.47%
• 3Y*: 100.52%
• 5Y*: 13.84%
• 10Y*: 4.15%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. SMMT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%
SMMT Summit Therapeutics Inc.	-19.33%	-1.99%	583.72%	-38.59%	57.99%	-42.77%	193.75%	39.13%	-89.62%	1.93%

Correlation

The correlation between VRNA and SMMT is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.13
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.11

Fundamentals

Market Cap VRNA : $9.72B SMMT : $10.94B
EPS VRNA : -$0.69 SMMT : -$1.60
PB Ratio VRNA : 34.92 SMMT : 20.04
Total Revenue (TTM) VRNA : $167.65M SMMT : $0.00
Gross Profit (TTM) VRNA : $159.52M SMMT : -$83.36K
EBITDA (TTM) VRNA : -$40.86M SMMT : -$738.34M

Return for Risk

VRNA vs. SMMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMMT

SMMT Risk / Return Rank: 25
SMMT Sharpe Ratio Rank: 24
SMMT Sortino Ratio Rank: 28
SMMT Omega Ratio Rank: 28
SMMT Calmar Ratio Rank: 21
SMMT Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. SMMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	VRNA	SMMT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.42	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.08	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.03	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.02	—

Drawdowns

Drawdown Indicators

	VRNA	SMMT	Difference
Max Drawdown Largest peak-to-trough decline	—	-95.75%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-52.76%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-62.26%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-91.78%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-95.75%	—
Current Drawdown Current decline from peak	—	-61.55%	—
Average Drawdown Average peak-to-trough decline	—	-57.64%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	34.32%	—

Volatility

Volatility by Period

	VRNA	SMMT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	22.47%	—
Volatility (6M) Calculated over the trailing 6-month period	—	56.53%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	75.95%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	185.12%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	144.63%	—

Dividends

VRNA vs. SMMT - Dividend Comparison

Neither VRNA nor SMMT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VRNA and SMMT in my portfolio?

VRNA and SMMT have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.